Biobanking 2013 Americas Summit


Background Info

The Biobanking 2013 Americas Summit

Paradigm Global Events is proud to present The Biobanking 2013 Americas Summit.

The biobanking industry is growing at an exponential rate, as researchers realise the growing importance of using samples for R&D. This growth leads to several issues, commercial, ethical, and scientific.

There are three main strands to this conference: firstly the growth of biobank networks: what does this mean to researchers, how can standards be harmonized, and how can organisations collaborate successfully?

Secondly, the conference will examine the ethical and legal issues of biobanking – including a look at ownership and informed consent; how can you get proper consent for the samples and how can you prove that all steps have been taken to ensure ownership protocols?

Lastly, data management is a huge issue for biobanks, as they grow in size, how are the samples stored, how is the data pertaining to the samples managed, and how can biobanks make effective use of data for their own purposes?

Not only will these three issues be discussed, but the event will also look at drug discovery for biobanks, quality assurance, and include a case study.

Don’t miss this opportunity – Reason to register today and – Why Attend?
• The most up-to-date information on Sample Storage and Tracking Issues
• Review the development and implementation of a tissue repository
• Hear the latest on the Stem Cell Banking
• Discuss the changing approaches to target-finding, drug development and patient treatment
• Gain a clearer insight on Green Banking
• Understanding the regulatory social and ethical frameworks
• Examine the quality concerns for existing biospecimen collections
• Recognise the importance of biobanking in rare disorders
• Analyse major challenges for biorepository management and implementation
• Get the latest update on the application

Worldwide Biobanking market is to increase by 30% to reach an estimated $183 Billion by 2015.

A “Must attend??? Biobanking Conference for 2013 for:
VPs, Directors, Heads, Managers of:
• Biobanks
• Tissue bank
• Biorepository / Biosample
• Translational Medicine
• Personalised Medicine
• Biomarkers Development
• Compound Management
• Digital Pathology
• Laboratory Automation
• Oncology Clinical Research
• Liquid Handling
• DNA Methylation
• Laboratory and Inventory
• Molecular Diagnostics
• Clinical Genetics, Pathology
• Genomics
• Scientific and Quality
• Privacy / Protections / Security
• R & D
• Quality Control
• Strategic Outsourcing
• Clinical Research
• Bioanlytical Chemistry
• Pharmacogenomics
• Proteomics
• Business Development
• Strategic Alliances
• Histopathology
• Non-clinical Biosample
• Health Science Policy
• Toxicology, Clinical Chemistry
• Clinical trials and Non-clinical R & D
• Procurement and Strategic Sourcing
• Informatics

Consultants, Academics, Regulatory bodies, Researchers, Biorepository Vendors, Government Officials


Half Day Pre- Conference Workshop – 9:00am – 13:00pm
The Biobanking 2013 Americas12th June 2013

“LIVE Bio-banking and Clinical Translations???
Led by: Dr. Vinagolu K. Rajasekhar, Senior Research Scientist,
Memorial Sloan-Kettering Cancer Center, New York, New York 10065

09:00 – 09:30 Coffee & Registration
09:30 – 13:30 Workshop
(Lunch and refreshment breaks included)

Workshop Summary

• Banking of live patient tissue specimens is vital for a number of reasons, including the application to tissue repair (e.g. restoring the lost eye function, repair of spinal cord injury), and disease modeling (e.g. cancers and neurodegenerative diseases) which offer an advancement over conventional studies such as cell cultures in vitro, or the genetically engineered mouse (GEM) models.

• Most human tumor tissue specimens are composed a heterogeneous cell population, which is dependent on the cellular context and on the developmental stages at which they were isolated. Thus, it is important to identify, isolate and characterize the target tissue cells in their natural 3D context and microenvironment.

• Discovery, characterization and validation of novel bio-markers in the target cells in vivo will be also of great value for developing precise diagnostics and targeted therapeutics.


Dr. Vinagolu K. Rajasekhar
“Live Biobanking as a Novel Strategy to Bridge the Gap between Patients’ Bedside to Lab Bench and back to the Patients???

Dr. Bernat Soria
“Celullar Medicaments: Changing the Paradigm???.

Dr. Neal Goodwin
“Patient Derived Xenograft (PDX) Resource for Clinical Advancement???

Dr. Elizabeth Bruckheimer
“Champions TumorGraft Platform: A Living Biobank of Clinically Relevant Models???

Key Speakers

Your Key Speakers
The Biobanking 2013 Americas Summit

Day 1

Day 1 – 13th June 2013

08:00-09:00 Registration & Coffee

09:00-09:10 Chairman’s welcome Dr. Vinagolu K. Rajasekhar

09:10-09:50 The challenges of implementing a successful enterprise-wide biobanking information system at Duke
• Identify functional requirements to meet the needs of all biobanks
• The RFP process
• Engaging the right subject matter experts
• Securing funding and what needs to be in the budget
• Creating and enforcing a Standard Biobanking Terminology
Helena Ellis, Director, Duke Biobank, Duke Translational Medicine Institute, Duke University

09:50-10:30 Ethical issues and Informed consent in Biobanking
• Dynamic consent process
• Blanket consent: is this practical?
• Coding to protect privacy
• Moving towards broad consent to biobank sampling
Ingrid A. Holm, MD, MPH Director, Phenotyping Core, Program in Genomics Divisions of Genetics and Endocrinology Boston Children’s Hospital

10:30-11:15 (Exhibitors Area) – Networking Morning Refreshments

11:15 – 11: 55 – Drug Discovery and Biobank
• What does the increase capability of biobanking mean for clinical research
• Open sourcing and using samples for drug development
• Challenges for drug development
Amelia Wall Warner, PharmD, Head Clinical Pharmacogenomics and Clinical Speciman Management , Merck & Co Inc

11:55-12:35 The Biobank’s in Generating Impact: Optimizing Research and Clinical Outcomes
Lisa B. Miranda, President and CEO, Biobusiness Consulting Incorporated

12:35-13:15 CRESALYS*, the unique Biobanking Management system to increase the value of your samples.

13:15-14:15 Networking Lunch

14:15-14:55 Tissue engineering of human corneal endothelial cells and Biobanking
Abolghassem Shahdadfar, MSc., PhD, is a Senior Reasearch Scientist in the Department of Ophthalmology at Oslo University Hospital

14:55-15:35 Participation, Progress and Public Trust in Biobanking
• Biobanking is key infrastructure for the future of precision medicine
• Biobanking depends on the willingness of people to give of their bodies
• Public trust is essential, but poorly understood and therefore often neglected
• Ethics governance approaches must aligned with donor preferences and expectations.
• Robust governance enhances repository quality and sustainability, enhancing research
• Models for innovation in biobank governance to be more dynamic, participatory, sustainable and scalable
• A variety of experimental approaches offer lessons for innovating new models
Dr. Benjamin Hurlbut, Assistant Professor, ASU School of Life Sciences

15:35-16:20 (Exhibitors Area) – Networking Afternoon Refreshments

A panel discusses the ethical considerations relating to biobanking
Dr. Benjamin Hurlbut, Assistant Professor, ASU School of Life Sciences.

17:00-17:15 Chairman comments and end of day oneDr. Vinagolu K. Rajasekhar

17:30 – Networking Drinks Reception at the Exhibitors area.
Take your discussions further and build new relationships in a relax and informal settings.

Day 2

Day 2 – 14th June 2013

08:00-09:00 Registration & Coffee

09:00-09:10 Chairman’s welcome Dr. Vinagolu K. Rajasekhar

09:10-09:50 Challenges and Obstacles in Collection of Genetic and Rare Disease samples
• What are the things to consider
• New test development for rare genetic disease
• Accessibility of database for research and future possibilities of treatment
• Collaborations for better understanding of rare genetic disease
Yaffa Rubinstein, PhD, Director of Patient Resources for Clinical and Translational Research, Office of Rare Diseases Research, (ORDR) National Center for Advancing Translational Science (NCATS)

09:50-10:30 Storage of Non-standard Samples- Squaring the circle
• Why storage of non-standard sample is different? (e.g. Stem cells)
• Techniques for non-standard sample storage
• Things to consider with non-standard samples
Dr. Vinagolu K. Rajasekhar, Senior Research Scientist, Memorial Sloan – Kettering Cancer Center

10:30-11:00 (Exhibitors Area) Networking Morning Refreshments

11:00-11:40 Effective data management and informatics
• Bigger biobanks means more data: effective data management strategies
• Facilities and Automation
Hank Wu, Director, Translational Informatics, Remedy Informatics

11:40-12:20 Global Biobanking Paradigm for the 21st Century Regenerative Medicine
• Regenerative Medicine; an Innovation Engine of Clinical Translational Research
• Personalized Medicine; new Regenerative Medicine Challenge
• Global Biobanking; Law, Ethics, Policy Considerations
• Strategic Priorities for Global Biobanking era.

12:20-12:30 – Chairman’s closing comments and end of conference – Dr. Vinagolu K. Rajasekhar

12:30- 14:00 – Networking Lunch




NanoEnTeK, Inc. is one of world leading company for life science research instruments. We are the manufacturer of innovative product lines such as automated cell counter, cell transfection system and cell image viewer. Recently we focus to develop the new business with bio banking equipment and our product, iSBS is total solution for sample banking.

BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid sample outsourcing models for the management of research assets, BioStorage Technologies manages the complete life-cycle of samples. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, and state-of-the-art virtual sample management and bioprocessing solutions, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany and a wholly-owned division in Singapore. For more information, visit

Cryo Bio System (CBS) is a worldwide provider of high-security sample storage products for cryopreservation and biorepositories.

We are dedicated to providing a storage solution to ensure high-quality, data rich samples. The CBS High-Security Straw, Tube, and Filling/Sealing equipment deliver a solution to impede cross-contamination in storage and decrease sample footprint. Cryo Bio System is committed to preserve valuable biological samples and viable cells for future use through quality, safety, traceability, and efficiency. For more information, visit

EXCILONE, is a French company base near Paris.

We design, develop and market innovative solutions for biobanking.
– RCL2®, Formalin free tissue fixative, to combine Histology and Molecular techniques
– SNAPFROST®, A liquid Nitrogen free snapfreezing system, to obtain the best morphology on frozen tissue section
– CRESALYS®, Biobank Management System to increase the value of your sample collection.
CRESALYS®, allows you to manage : Patient demographics, Epidemiology and History, Family link, Patient follow up, Clinical Data, Pathology Report, Specimen Reception and storage, Specimen Retrieval, Quality Management,…



Media Partners

PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE’s more than 25,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers. For further information please visit:

Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. For further information please visit:

European Life Science is the premier journal devoted to presenting outstanding research and researchers within the life science fields. For further information please visit: is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services. is a unique video news channel for laboratory application and product information. For further information please visit:

InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to, Pharmafile and Pharmafocus. For further information please visit: is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email:

BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit

Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision- makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ top issues and the solutions top-tier vendors can provide. For further information please visit: